Quantamental Technologies LLC Regeneron Pharmaceuticals, Inc. Transaction History

Quantamental Technologies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $543,031 - $659,922	798 New	798 $655,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $811,743 - $952,658	-1,364 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $741,306 - $915,203	1,364 New	1,364 $861,000
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $318,667 - $376,455	-674 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $301,096 - $369,486	674 New	674 $319,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $309,460 - $393,363	-647 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $207,005 - $250,119	-380 Reduced 37.0%	647 $362,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $506,639 - $661,305	1,027 New	1,027 $640,000
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $224,512 - $308,361	-819 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $60,981 - $71,000	-223 Reduced 21.4%	819 $227,000
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $312,183 - $432,242	1,042 New	1,042 $326,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.